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Abstract 
 
Metabolic disorders are a major burden for public health systems globally. Regular exercise 
improves metabolic health. Pharmacological targeting of exercise mediators might facilitate 
physical activity or amplify the effects of exercise. The peroxisome proliferator-activated 
receptor γ coactivator 1α (PGC-1α) largely mediates musculoskeletal adaptions to exercise, 
including lipid refueling, and thus constitutes such a putative target. Paradoxically, forced 
expression of PGC-1α in muscle promotes diet-induced insulin resistance in sedentary 
animals. We now show that elevated PGC-1α in combination with exercise preferentially 
improves glucose homeostasis, increases Krebs cycle activity, and reduces the levels of 
acylcarnitines and sphingosine. Moreover, patterns of lipid partitioning are altered in favor of 
enhanced insulin sensitivity in response to combined PGC-1α and exercise. Our findings 
reveal how physical activity improves glucose homeostasis. Furthermore, our data suggest 
that the combination of elevated muscle PGC-1α together with exercise constitutes a 
promising approach for the treatment of metabolic disorders. 
 
Keywords: PGC-1α; exercise mimetics; insulin resistance; metabolic syndrome; skeletal 
muscle 
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Introduction 
 
Metabolic disorders are major threats to public health. Currently, almost two thirds of adult 
Americans are overweight (1). Importantly, excessive body weight fosters the development of 
comorbidities such as hypertension, dyslipidemia, cardiovascular disease and diabetes (2; 3). 
 
Regular exercise improves metabolic parameters (4-6), promotes weight loss (6) and prevents 
adiposity relapse after successful weight loss (7). Problematically, people suffering from 
metabolic disorders are often unable or unwilling to achieve the levels of physical activity that 
are required to elicit health benefits. The auxiliary use of substances that mimic the plastic 
adaptations to exercise, so-called exercise mimetics (8), constitutes a seemingly attractive 
therapeutic approach to ease and support physical activity, or amplify the effects of exercise, 
at least when potential drawbacks and limitations are ignored (9; 10). As a key regulator of 
muscle plasticity (11; 12), the peroxisome proliferator-activated receptor γ coactivator 1α 
(PGC-1α) constitutes a potential target for such drugs (13). 
 
Elevated expression of PGC-1α in skeletal muscle increases endurance performance (14). 
PGC-1α acts as a transcriptional coactivator that promotes the expression of several 
transcription factors, some of which it subsequently co-activates (15). PGC-1α then induces 
mitochondrial biogenesis (16; 17), promotes angiogenesis (18) and increases peak oxygen 
consumption and fatigue resistance (14; 17; 19). Moreover, PGC-1α drives slow fiber type-
specific calcium handling (17) and switching from fast, glycolytic towards slow, oxidative 
fibers (19). PGC-1α also increases metabolic flexibility (20). Importantly, PGC-1α promotes 
lipid (21) and glucose refueling in skeletal muscle (22) and thereby ensures the provision of 
substrates during exercise. 
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Paradoxically, despite the strong promotion of an exercised muscle phenotype, elevated 
expression of PGC-1α in sedentary mice exacerbates diet-induced insulin resistance as 
indicated by impairments in glucose disposal rates and muscle glucose uptake under 
hyperinsulinemic-euglycemic clamp conditions (23). Elevated lipid refueling in muscle-
specific PGC-1α transgenic (MPGC-1α TG) animals, in combination with a sedentary 
lifestyle, likely underlies the pronounced detrimental effects of a high-fat diet (21). We 
hypothesized that the metabolic impairments in sedentary MPGC-1α TG animals fed a high-
fat diet is improvable in response to exercise. The aim of the current study was to 
longitudinally explore the potential therapeutic use of elevation of PGC-1α in combination 
with exercise in the treatment of diet-induced metabolic syndrome. 
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Materials and Methods 
 
Animals 
Male muscle-specific PGC-1α transgenic mice (MPGC-1α TG) (19) and control littermates 
were maintained in a fixed 12-h light/dark cycle on a pellet chow diet and free access to 
water. To induce insulin resistance, animals were administered a high-fat diet consisting, by 
energy, of 60% fat for two weeks. This time span was sufficient to induce impairments in 
glucose and insulin tolerance, which were more pronounced in MPGC-1α TG animals 
compared to control littermates (data not shown). Thereafter, all animals continued to 
consume the high-fat diet for another 3.5 weeks. During these 3.5 weeks, half of the animals 
remained sedentary (8 wild-type and 8 MPGC-1α TG mice) while the other half (8 wild-type 
and 8 MPGC-1α TG mice) underwent treadmill training three times per week separated by an 
intermittent day of recovery. All animals were sacrificed 24hrs after the last bout of exercise. 
Studies were performed according to criteria outlined for the care and use of laboratory 
animals and with approval of the Swiss authorities. 
 
Body composition 
Body composition was determined by EchoMRI qNMR (Echo Medical Systems). 
 
Locomotor activity, endurance training and muscle strength 
Locomotor activity was assessed by CLAMS (Columbus instruments). Endurance training 
was performed on a motorized treadmill (Columbus Instruments). After acclimatization, 
maximal endurance capacity was determined. The detailed protocol was as follows: 10m/min 
for 5min, then increase by 2m/min every 5 minutes up to 26m/min. The speed of 26m/min 
was then kept until exhaustion. Mice subsequently trained 3 days per week for 3.5 weeks. 
This training period started at 75% of maximal endurance capacity and exercise levels were 
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then gradually increased to reach 115% by the end of the training period. Maximal force was 
tested in vivo using a grip strength meter (Chatillon) as described (17). 
 
RNA extraction and RT-PCR 
Frozen tissues were homogenized under liquid nitrogen and total RNA was isolated using 
Trizol reagent (Invitrogen). Reverse transcription was carried out using random hexamer 
primers (Promega). Real-time PCR analysis (Power SYBR Green Master Mix, Applied 
Biosystems) was performed using the StepONE Detector. Relative expression levels for each 
gene of interest were calculated with the Ct method and normalized to the expression of the 
Tata box-binding protein (TBP).  
 
Enzymatic activities 
Citrate synthase (CS) activity was assessed according to the protocol by Srere et al (24). 
Fatty acid synthase (FAS) and Glucose 6-phosphate dehydrogenase (G6PDH) activity were 
measured as described (21). 
 
Glucose uptake 
Isolated EDL muscles were blotted on filter paper, weighed and washed in Krebs-Ringer 
bicarbonate buffer (KRBB: 117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 
1.2 mM MgSO4, 24.6 mM NaHCO3, pH 7.4). 2-deoxyglucose uptake was assessed in fresh 2 
ml KRBB containing 1 mmol/l 2-deoxy-D[1,2-3H]glucose (1.5 μCi/ml) and 7 mmol/l D-
[14C]mannitol (0.45 μCi/ml) (Amersham Biosciences) at 30°C for 10 min (25). To terminate 
the transport, muscles were dipped into ice-cold KRBB buffer containing 80 μM cytochalasin 
B. Muscles were further processed by incubating in 300 μl 1N NaOH at 80°C for 10 min, 
neutralized with 300 μl 1N HCl, and particules were precipitated by centrifugation at 12,000 
× g for 5 min (26). Radioactivity in the lysates was quantified using a Beckman liquid 
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scintillation counter. All values were corrected for initial tissue weight and expressed as fold 
change compared to control animals. 
 
Muscle ROS 
To monitor intracellular generation of ROS, 2′,7′-dichlorofluorescein diacetate (H2DCFDA) 
(Sigma) was used as previously described (20). 
 
Blood acylcarnitine and muscle lipid determination  
Acylcarnitine concentrations were measured as described (20). Briefly, aylcarnitines were 
extracted from dried blood spots using methanol containing eight isotopically labeled internal 
standards (Cambridge Isotopes Laboratories) and analyzed without prior sample 
derivatization. Precursor ions of m/z 85 in the mass range of m/z 150 to 450 are acquired on a 
PerkinElmer API 365 LC-ESI-MS/MS instrument. 
Analyses of lipids were carried out using methods described (27; 28). Lipid extracts were 
prepared using a modified Bligh/Dyer extraction procedure, spiked with appropriate internal 
standards and analyzed using an Agilent 1200 HPLC system coupled with an Applied 
Biosystem Triple Quadrupole/Ion Trap mass spectrometer (3200Qtrap). Briefly, separation of 
individual lipid classes of polar lipids by normal phase HPLC was carried out using a 
Phenomenex Luna 3u silica column (i.d. 150x2.0 mm) with the following conditions: mobile 
phase A (chloroform:methanol:ammonium hydroxide, 89.5:10:0.5), B (chloroform:methanol: 
ammonium hydroxide:water, 55:39:0.5:5.5); flow rate of 300 µl/min with gradient elution as 
described previously (28). Individual lipid species were quantified by referencing to spiked 
internal standards. PC-14:0/14:0, PE-14:0/14:0, Sphingosine-17:0 and C17-Cer were obtained 
from Avanti Polar Lipids. TAG, DAG and CE were analyzed using a modified version of 
reverse phase HPLC/ESI/MS described previously (27). Briefly, separation of TAG and CE 
from polar lipids was carried out on an Phenomenex Kinetex C18 column (i.d. 4.6X100mm) 
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using an isocratic mobile phase chloroform:methanol:0.1M ammonium acetate (100:100:4) at 
a flow rate of 150 µl/min. TAG were calculated as relative contents to the spiked d5-TAG 
48:0 internal standard (CDN isotops), while cholesterol esters were normalized to 
corresponding d6-C18 cholesterol ester (CDN isotops). DAG species were quantified using 
4ME 16:0 Diether DG as an internal standard (Avanti Polar Lipids). 
 
Glucose and insulin tolerance tests 
Animals were fasted for 16 h and 4 h before i.p. injection of 2 g/kg glucose and 0.8 U/kg 
insulin, respectively. Blood was obtained at intervals of 15 minutes from the tail vein, and 
glucose levels were determined using a standard glucometer. 
 
Histology 
Muscles were embedded in OCT and frozen in cooled isopentane. SDH stainings were 
performed on 8µm cryosections by exposing the sections to succinate (27mg/ml) and nitro-
blue tetrazolium (1mg/ml). Cox staining was similarly performed with cytochrome c 
(0.1mg/ml) and diaminobenzidine (0.5mg/ml). Mitotracker staining was performed as 
described (20). 
 
Cell culture experiments 
Mouse C2C12 myoblasts were maintained in DMEM supplemented with 10% fetal bovine 
serum in a subconfluent culture. C2C12 myoblasts were fused into myotubes by using DMEM 
with 2% horse serum. On the third day of differentiation, myotubes were infected with 
adenoviral vectors for GFP or PGC-1α. Glucose uptake was determined two days following 
adenoviral infection in the presence of vehicle, 50 µM cerulenin or sphingosine and 100 nM 
insulin. Both drugs were added 3 mins prior to insulin stimulation. Glucose transport was 
assessed in 10µM 2-deoxy-glucose (0.5µCi/ml 2-deoxy-D[1,2-3H]glucose) in Hepes buffer 
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(140mM NaCl, 20mM Hepes, pH 7,4, 5mM KCl, 2.5 mM MgSO4 and 1mM CaCl2). After 10 
mins, glucose uptake was stopped by addition of ice cold PBS, cells were washed thrice and 
immediately lysed by addition of 0.05M NaOH. Radioactivity in the lysates was quantified 
using a Beckman liquid scintillation counter. All values were corrected for total protein and 
expressed as fold change compared to control animals. 
 
Data analysis and statistics 
All data are presented as means ± SE. The data were analyzed by factorial ANOVA for the 
main effects of genotype (wild-type versus MPGC-1α TG mice)(@), treatment (sedentary 
versus exercised)(#), and group-times-treatment interactions (x). Student t-test were applied to 
assess the effects of treatment (sedentary versus exercised)(*) and genotype (wild-type versus 
MPGC-1α TG mice)(§) between two individual groups. Levels of significance are indicated 
as follows: single symbol p< 0.05; double symbols p< 0.01; triple symbols p<0.001.  
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Results 
 
General parameters 
MPGC-1α TG animals (sedentary and exercised) were significantly heavier than control 
littermates and tended to display an elevated fat, but unaltered lean mass (Table 1). Tibialis 
anterior and epididymal fat pad mass was significantly increased in MPGC-1α TG animals.  
The level of exercise in our study was insufficient to counteract many of the detrimental 
effects of the high-fat diet and no general body weight loss, changes in body composition or 
reductions in specific tissue weights occurred in response to exercise in MPGC-1α TG and/or 
control mice (Table 1). We can therefore exclude that any metabolic changes observed in our 
study are related to body weight or fat mass loss.  
 
The effect of training is amplified by elevated PGC-1α  
Muscle function was assessed under different experimental settings. No changes in maximal 
force generation and spontaneous locomotor activity were observed across the 4 groups 
(Table 1).  
 
MPGC-1α TG animals display an elevated exercise performance on standard chow diet (14). 
Interestingly, the two initial weeks of high-fat feeding completely abrogated this effect (Wild-
type and MPGC-1α TG ran 445±33m and 449±39m, respectively). During the subsequent 
3.5-week training period, MPGC-1α TG and wild-type animals exercised in parallel at exactly 
the same relative workload to ascertain maximal comparability between the exercising 
groups. At the end of the training period, the exercise benefit was more pronounced in 
MPGC-1α TG animals compared to control littermates and thereby again resembled the 
improved endurance of PGC-1α TG mice on regular chow diet (14). In fact, the maximal 
endurance performance in response to training increased by 43% and 102% in wild-type and 
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MPGC-1α TG animals, respectively (Table 1).  The impact of exercise in wild-type controls 
resembled previously published data in the same mouse strain on chow diet (29). 
 
Endurance exercise preferentially improves glucose homeostasis at elevated PGC-1α 
levels  
We have reported that overall glucose homeostasis is unaltered in MPGC-1α TG animals 
under standard laboratory conditions (20). Paradoxically, when challenged by a high-fat diet 
and under hyperinsulinemic-euglycemic clamp conditions, MPGC-1α TG animals display an 
accelerated development of insulin resistance compared to control littermates (23). Exercise 
preferentially improved glucose (Fig. 1A and B) and insulin (Fig. 1C and D) tolerance in 
MPGC-1α TG by 28% and 17%, respectively. In comparison, glucose tolerance improved 
only by 6% (Fig. 1A and B) and insulin tolerance (Fig. 1C and D) was unaltered in response to 
exercise in wild-type animals. Thus, the beneficial effects of exercise on whole body glucose 
homeostasis are amplified by elevated PGC-1α levels. 
 
Since skeletal muscle is a major contributor to overall glucose homeostasis, we assessed the 
expression of genes involved in muscle glucose uptake. We primarily focused on gene 
transcription as exercise alters the transcriptional profile of skeletal muscle and since PGC-1α 
acts as a transcriptional co-activator. Glucose transporter 4 (GLUT4) mRNA expression 
levels were reduced in tibialis anterior of sedentary, high fat diet-fed MPGC-1α TG animals 
and restored by exercise (Fig. 1E). Moreover, the mRNA expression of hexokinase II (HK II) 
was highest in trained MPGC-1α TG animals (Fig. 1E). In line with these findings, muscle 
glucose uptake was decreased in sedentary, but preferentially improved by 93% in trained 
MPGC-1α TG animals (Fig. 1F). In contrast, exercise increased glucose uptake in wild-type 
animals by only 22% (Fig. 1F). Intriguingly, muscle PI3K activity, an early marker of insulin 
sensitivity and key element in insulin signaling, was higher in MPGC-1α TG animals, but 
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unaltered by exercise (Fig. 1G). This absence of an effect of exercise on proximal insulin 
signaling is further underlined by the fact that the insulin responsiveness within the first 30 
mins following insulin injection was similar between sedentary and exercised animals (Fig. 
1C and D) and (supplemental Fig. S1). 
 
Elevated PGC-1α potentiates the effect of exercise on Krebs cycle activity 
We next assessed the capacity for muscle lipid uptake. MPGC-1α TG mice showed elevated 
levels of lipoprotein lipase (LPL) and cluster of differentiation 36 (CD36), which are involved 
in lipid uptake (Fig. 2A and B). 
We then examined genes regulating lipid oxidation and Krebs cycle, namely carnitine 
palmitoyl transferase 1b (CPT-1b), malonyl CoA decarboxylase (MCD), acetyl CoA 
carboxylase 2 (ACC2) and citrate synthase (CS). While all of the genes were elevated in 
MPGC-1α TG animals, the majority of them were not significantly altered by exercise (Fig. 
3A). In contrast, the enzymatic activity of citrate synthase, which is a marker of mitochondrial 
oxidation and central to both glucose and lipid oxidation, was further boosted by exercise at 
elevated PGC-1α levels (~28% compared to sedentary MPGC-1α TG animals) (Fig. 3B). In 
control littermates, the exercise regimen had no effect on citrate synthase activity in 
accordance with previous studies under high-fat feeding (30; 31).  
 
Exercise restores acylcarnitine profiles in MPGC-1α TG animals to wild-type levels 
In sedentary, high fat-fed MPGC-1α TG animals higher amounts of palmitoylcarnitine 
(C16:0) were released into the circulation, while exercise diminished the levels of 
palmitoylcarnitine in MPGC-1α TG animals (Fig. 3C). No major changes were observed 
across the 4 groups for the patterns of mono- (Fig. 3D) and poly- (Fig. 3E) unsaturated 
acylcarnitines. Total carnitine and acetylcarnitine (C2) levels were elevated in sedentary 
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MPGC-1α TG animals and returned to wild-type levels in response to exercise (Fig. 3F and 
G).  
 
Unaltered OXPHOS activity in response to exercise 
The increased levels of acetylcarnitine in sedentary MPGC-1α TG animals suggest that the 
amount of lipids taken up and fuelled into β-oxidation exceeded the energetic demand of the 
Krebs cycle and oxidative phosphorylation. We thus tested whether elements of the electron 
transport chain are altered in response to exercise on a high-fat diet. While all of these genes 
were elevated in MPGC-1α TG animals, gene expression patterns were not affected by 
exercise (Fig. 4A). Exercise increased the activity of succinate dehydrogenase (SDH), an 
enzyme that contributes to the Krebs cycle and oxidative phosphorylation and thereby links 
these processes (Fig. 4B and supplemental Fig. S2). In MPGC-1α TG animals, exercise 
resulted in the highest activity of succinate dehydrogenase. In contrast, the activity of 
cytochrome c oxidase (COX), which constitutes an element of OXPHOS, but not of the Krebs 
cycle, was elevated in MPGC-1α TG animals, while no additional effect of exercise could be 
observed (Fig. 4B and supplemental Fig. S2). These data suggest that OXPHOS activity is not 
rate-limiting within our experimental context.  
We next determined the relative mRNA expression of genes implicated in reactive oxygen 
species (ROS) generation and detoxification since ROS can impair insulin sensitivity (32; 33) 
(Fig. 4C). The mitochondrial superoxide dismutase 2 (SOD2), which transforms superoxides 
into H2O2, was elevated in MPGC-1α TG animals. Moreover, catalase (CAT), which 
detoxifies H2O2, was simultaneously increased. Overall H2O2 was therefore not different (Fig. 
4D). 
 
Additive increases in de-novo lipogenesis by elevated PGC-1α and exercise 
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We have previously demonstrated that PGC-1α promotes de-novo lipogenesis and pentose 
phosphate activity (rate-limited by glucose-6-phosphate dehydrogenase (G6PDH)) and that 
this partially drives glucose uptake into trained muscle (21). Interestingly, the activities of 
G6PDH and fatty acid synthase (FAS) remained higher in MPGC-1α TG animals on a high-
fat diet and increased even further with exercise (Fig. 5A and B). 
Given the elevated lipogenesis in MPGC-1α TG animals, we next investigated whether lipid 
partitioning in skeletal muscle is altered. Triglyceride (TAG) levels were comparable between 
sedentary wild type and MPGC-1α TG animals on a high fat diet and increased to a similar 
extent in both genotypes following chronic exercise (Fig. 5C). 
We found elevated levels of diacylglycerols (DAG) (Fig. 5D) in the MPGC-1α TG animals, 
while the ceramide content was unaltered (Fig. 5E). Moreover, phosphatidylcholine (Fig. 5F) 
and phosphatidylethanolamine (Fig. 5G) levels were elevated in MPGC-1α transgenic 
animals. Exercise had no additional effect on the levels of these lipid species. In contrast, 
sphingosine levels were significantly increased in MPGC-1α TG animals and markedly 
reduced by exercise (Fig. 5H). 
 
Inhibition of FAS or high sphingosine prevent glucose uptake in muscle cells in vitro 
Given the elevated FAS activity in MPGC-1α TG animals that even persists during high-fat 
feeding, we investigated the general role of FAS in glucose uptake into isolated muscle cells 
free of interspersed adipose tissue. Pharmacological inhibition of FAS by cerulenin blunted 
glucose uptake in muscle cells and this inhibitory effect was more pronounced following 
over-expression of PGC-1α (Fig. 6A). 
The accumulation of sphingosine in muscle of MPGC-1α TG animals prompted us to 
investigate the impact of sphingosine on glucose homeostasis. Sphingosine diminished 
glucose uptake in muscle cells and completely abrogated the stimulating effect of insulin at 
high levels of PGC-1α (Fig. 6B). 
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Discussion 
 
The role of skeletal muscle mitochondrial function and in particular, that of its key regulator 
PGC-1α in the etiology of type 2 diabetes remains controversial (34; 35). Studies in animal 
models for PGC-1α in skeletal muscle have not conclusively revealed how modulation of this 
coactivator affects peripheral insulin sensitivity so far (20; 23; 36). We have now 
demonstrated in a model of continuous high-fat feeding that elevated expression of PGC-1α 
preferentially improves whole body and muscle glucose homeostasis when combined with 
exercise. In stark contrast, elevated expression of PGC-1α favors the development of diet-
induced insulin resistance in the sedentary state. The beneficial metabolic effects of concerted 
exercise and PGC-1α expression comprise augmented Krebs cycle activity, reduction in 
acetylcarnitine levels, elevated glucose uptake for de-novo lipogenesis and altered lipid 
partitioning in favor of enhanced insulin sensitivity in skeletal muscle (Fig. 7). 
 
In sedentary MPGC-1α TG mice fed a high-fat diet, the high lipid provision exceeds the 
energetic demand of β-oxidation as indicated by the release of palmitoylcarnitine (C16:0) into 
the circulation. The parallel increase in citrate synthase activity is insufficient to cope with the 
metabolites deriving from lipid oxidation and, as a consequence, acetylcarnitine (C2) levels 
rise, which might impair glucose homeostasis (37; 38) (Fig. 7) possibly by activation of 
insulin de-sensitizing nuclear factor κB (NFκB). NFκB activation is sufficient to impair 
glucose homeostasis by interference with insulin receptor substrate and protein kinase B 
(PKB) phosphorylation, as well as GLUT4 translocation (39). Acylcarnitine species potently 
activate NFκB to a degree which is even higher than saturated fatty acids (37), a classical 
stimulus of NFκB. Whether this effect of acylcarnitines is mechanistically brought about by 
direct interference with NFκB or activation of upstream signaling events, such as toll-like 
receptor stimulation, remains unresolved.  
   18
 
In the sedentary state, Krebs cycle activity is less required for ATP regeneration and citrate is 
exported into the cytoplasm for de-novo lipogenesis. An increase in lipogenesis is indeed 
corroborated by the augmented phosphate pathway and FAS activity, which persist in 
sedentary transgenic animals in spite of abundant dietary fat. In MPGC-1α TG mice the 
increased mitochondrial biogenesis is associated with elevated levels of phosphatidylcholine 
(PC) and phosphatidylethanolamine (PE), which together account for more than 75% of total 
membrane phospholipids (40), and of diacylglycerol (DAG), which constitutes another 
membrane component. Moreover, sedentary MPGC-1α TG animals display markedly higher 
levels of sphingosine, which is implicated in PI3K-independent insulin resistance in 
adipocytes (41-43).  We have now analogously demonstrated a direct effect of sphingosine on 
glucose uptake in skeletal muscle cells in vitro. Consistently, our in vivo data on skeletal 
muscle show markedly elevated sphingosine levels along with reduced muscle glucose 
uptake, but higher PI3K activity in sedentary MPGC-1α TG animals.  
The mechanisms that underlie the detrimental effect of sphingosine remain obscure. In non-
muscle cells, sphingosine exerts pleiotropic effects on insulin signaling. It inhibits Protein 
Kinase C (PKC) isoforms required for proper insulin signaling (42), but activates a truncated 
form of PKCδ, which is implicated in the development of insulin resistance (44). Moreover, 
sphingosine interferes with the MAPK pathway and activates protein phosphatases which 
target PKB, a downstream target of PI3K (44). Thus, sphingosine seems to target multiple 
mediators of insulin signaling. 
 
In stark contrast to sedentary, high fat-fed mice, regular endurance exercise decreased the 
levels of C16:0 and C2 in trained MPGC-1α TG animals. Exercise accordingly increased β-
oxidation and Krebs cycle activity in MPGC-1α TG animals, allowing complete oxidation.  
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Interestingly, an additional elevation in FAS activity occurs in skeletal muscle of exercised 
MPGC-1α TG animals. Regular exercise and exercise-independent activation of PGC-1α both 
promote FAS transcription in skeletal muscle (21). Concomitantly, PGC-1α increases glucose 
uptake (21; 22), but impedes glycolytic fluxes (22) thereby shunting glucose towards 
glycogen storage (22) and the pentose phosphate pathway for the generation of NADPH (21), 
a prerequisite for de-novo lipogenesis. In adipocytes, metabolic flux through de-novo 
lipogenesis determines insulin sensitivity and glucose uptake to a significant extent (45; 46). 
We have now shown by pharmacological intervention that in isolated muscle cells, FAS 
activity similarly plays a role in regulating glucose uptake. The possibility thus arises that the 
elevated pentose phosphate pathways activity and de-novo lipogenesis in exercised animals on 
a high fat diet might similarly be implicated in driving glucose uptake in skeletal muscle. 
Trained transgenic animals subsequently display a different pattern of lipid partitioning. In 
addition to the elevated levels of membrane components (DAG, PC and PE), triglycerides 
(TG) are increased in response to exercise. According to the “athlete’s paradox”, elevated 
lipogenesis and high levels of intramyocellular triglycerides and even diacylglycerides co-
exist with improved insulin sensitivity and thus per se do not seem to constitute predictors of 
muscle insulin sensitivity (47; 48).  
Importantly, exercise reduced the levels of sphingosine in MPGC-1α TG mice and thus 
relieved its potential inhibitory effect on glucose uptake. The negative effect of sphingosine 
on glucose uptake is further counteracted in exercised MPGC-1α TG mice by elevated levels 
of triglycerides, which have been shown to inhibit sphingosine activity in a dose-dependent 
manner (49). Thus, exercise at elevated muscle levels of PGC-1α decreased 
palmitoylcarnitine and acetylcarnitine levels and diverted de-novo synthesized lipids away 
from sphingosine biosynthesis towards triglyceride storage. Combined elevated expression of 
PGC-1α and exercise therefore promote lipid partitioning in favor of enhanced insulin 
sensitivity (Fig. 7). 
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In our study, exercise exerts only moderate effects on glucose homeostasis in the context of 
continuous high-fat feeding similar to other studies where daily high fat-feeding largely 
antagonized the beneficial effects of exercise (50-52). We have specifically chosen a mild 
exercise regimen to avoid potentially confounding effects of reduced adiposity. Nevertheless, 
during the development of insulin resistance (two weeks of high-fat feeding in the sedentary 
state), the transgenic elevation of PGC-1α levels led to a more severe starting (pre-exercise) 
insulin resistance in MPGC-1α TG animals. This was unavoidable in our model, but partially 
compromises the interpretation of our data. Nonetheless however, the strong interactive effect 
of exercise and PGC-1α clearly demonstrates that exercise exerts its beneficial effects 
preferentially at elevated muscle PGC-1α levels and that the significant differences in exercise 
responses are unlikely related to differences in the absolute amount of muscle work due to the 
slightly higher body weight in MPGC-1α TG animals.  Timely coordination of the expression 
of PGC-1α and dietary intervention would therefore presumably culminate in an exclusively 
positive outcome on metabolic health.  
 
In conclusion, we demonstrate that exercise preferentially improves exercise capacity and 
metabolic parameters at high levels of muscle PGC-1α in the context of energy-dense 
nutrition. Moreover, we provide novel insights into metabolic alterations that affect glucose 
homeostasis in the insulin-resistant and trained muscle, respectively. Although our data 
suggest that elevation of PGC-1α, as a mono-therapy, is detrimental in sedentary patients 
exposed to a Western diet, targeting PGC-1α to further amplify the effects of exercise 
regimens might represent a novel avenue to improve skeletal muscle function and to achieve 
metabolic benefits. In light of the growing prevalence of metabolic disorders, which are 
favored by a sedentary lifestyle, the use of adjuvants to exercise to ease physical activity and 
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enhance exercise effects in people with a low drive to move, might gain profound medical and 
economical interest in the coming years. 
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Table 1 General parameters 
Body weight, body composition, individual tissue weights and performance parameters in 
MPGC-1α TG mice and control littermates. 
Values are expressed as means ±SE (n =8 per group); Overall effect of genotype (wild-type 
vs. MPGC-1α TG): @; Effect of training (sedentary vs. exercised): #; genotype times training 
interaction: x were assessed by ANOVA. Comparison between two individual groups: effects 
of training (sedentary versus exercised)(*) and genotype (wild-type versus MPGC-1α TG 
mice)(§) were assessed by t-test. Single symbol: p<0.05; double symbols: p<0.01; triple 
symbols: p<0.001.  
 
 wild-type MPGC-1α TG ANOVA
        
 sedentary exercised sedentary exercised genotype training interaction 
        
body weight 
(g) 
30.1±0.5 31.0±0.6 32.4±0.8§ 32.8±0.6§ @@ N.S N.S
fat mass (g) 5.2±0.3 5.5±0.3 5.6±0.3 6.4±0.5 p=0.065 N.S N.S
lean mass (g) 22.5±0.5 22.9±0.5 23.0±0.4 22.8±0.4 N.S N.S N.S
        
heart (mg) 121±6 122.1±2.3 128±5.6 134.1±3.7 p=0.055 N.S N.S
        
tibialis (mg) 39.5±1.2 43.1±1.4 46.7±2§§ 43.9±1.1 @ N.S N.S
EDL (mg) 9.9±0.6 10.7±1.1 11.9±0.7 10.9±0.2 N.S N.S N.S
soleus (mg) 9.3±0.6 10.8±0.5 10.8±0.5 10.2±0.5 N.S N.S N.S
gastrocnemius 
(mg) 
159.9±9.7 157.9±5.2 157.4±6 153.2±3.5 N.S N.S N.S
        
epididymal 
fat (mg) 
403.1±39.7 453.9±38.6 550.7±66.3 527.5±60.3 @ N.S N.S
        
maximal force 
(front) (N) 
0.91±0.04 0.99±0.04 0.91±0.05 0.91±0.02 N.S N.S N.S
maximal force 
(hind) (N) 
1.98±0.1 2.03±0.14 1.99±0.08 2.02±0.06 N.S N.S N.S
        
locomotor 
activity 
(counts/24hrs) 
14000±1844 14303±2859 15034±3548 14268±1673 N.S N.S N.S
        
endurance 
(distance) (m) 
435±22 624±30 487±36*** 985±39***,§§§ @@@ ### xxx 
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Figure legends 
 
Fig. 1 Whole body and muscle glucose homeostasis  
(A and B) Glucose tolerance test (GTT) excursion curves (A) and corresponding area under 
the curve (B) 
(C and D) Insulin tolerance test (ITT) excursion curves (C) and corresponding area under the 
curve (D) 
(E) Relative gene expression of mediators of glucose uptake in skeletal muscle assessed by 
RT-PCR 
(F) Glucose uptake into isolated skeletal muscle measured by the 2-deoxglucose technique  
(G) IRS-1-associated muscle PI3K activity  
All values are expressed as means ±SE (n =8 per group); Effect of genotype (wild-type vs. 
MPGC-1α TG): @; Effect of training (sedentary vs. exercised): #; genotype times training 
interaction: x were assessed by ANOVA. Comparison between two individual groups: effects 
of training (sedentary versus exercised)(*) and genotype (wild-type versus MPGC-1α TG 
mice)(§) were assessed by t-test. Single symbol: p<0.05; double symbols: p<0.01; triple 
symbols: p<0.001. 
 
 
Fig. 2 Lipid uptake  
Relative mRNA expression of LPL (A) and CD36 (B) in MPGC-1α TG mice and control 
littermates. All values are expressed as means ±SE (n =8 per group); Overall effect of 
genotype (wild-type vs. MPGC-1α TG): @; Effect of training (sedentary vs. exercised): #; 
genotype times training interaction: x were assessed by ANOVA. Comparison between two 
individual groups: effects of training (sedentary versus exercised)(*) and genotype (wild-type 
versus MPGC-1α TG mice)(§) were assessed by t-test. Single symbol: p<0.05; double 
symbols: p<0.01; triple symbols: p<0.001. 
 
 
Fig. 3 β-oxidation, TCA cycle and acylcarnitines 
(A) Relative gene expression of regulators of lipid oxidation and TCA cycle. 
(B) Citrate synthase activity 
(C) Levels of saturated acylcarnitines (SFA) 
(D) Levels of mono-saturated acylcarnitines (MUFA) 
(E) Levels of poly-saturated acylcarnitines (PUFA) 
(F) Total carnitine levels 
(G) Acetylcarnitine levels 
All values are expressed as means ±SE (n =8 per group); Overall effect of genotype (wild-
type vs. MPGC-1α TG): @; Effect of training (sedentary vs. exercised): #; genotype times 
training interaction: x were assessed by ANOVA. Comparison between two individual 
groups: effects of training (sedentary versus exercised)(*) and genotype (wild-type versus 
MPGC-1α TG mice)(§) were assessed by t-test. Single symbol: p<0.05; double symbols: 
p<0.01; triple symbols: p<0.001. 
 
 
Fig. 4 Oxidative phosphorylation and reactive oxygen species 
(A) Relative gene expression of elements of oxidative phosphorylation. 
(B) Succinate dehydrogenase (SDH) (upper panel), cytochrome c oxidase (Cox) (middle 
panel) and mitotracker green staining (lower panel). 
(C) Relative gene expression of ROS detoxifying enzymes. 
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(D) H2O2 levels in skeletal muscle. 
All values are expressed as means ±SE (n =8 per group); Overall effect of genotype (wild-
type vs. MPGC-1α TG): @; Effect of training (sedentary vs. exercised): #; genotype times 
training interaction: x were assessed by ANOVA. Comparison between two individual 
groups: effects of training (sedentary versus exercised)(*) and genotype (wild-type versus 
MPGC-1α TG mice)(§) were assessed by t-test. Single symbol: p<0.05; double symbols: 
p<0.01; triple symbols: p<0.001. 
 
 
Fig. 5 Muscle lipid species 
(A) G6PDH activity and (B) FAS activity  
(C) Triglycerides (TAG) 
(D) Diacylglycerides (DAG) 
(E) Ceramide 
(F) Phosphatidylcholine 
(G) Phosphatidylethanolamine 
(H) Sphingosine 
All values are expressed as means ±SE (n =8 per group); Overall effect of genotype (wild-
type vs. MPGC-1α TG): @; Effect of training (sedentary vs. exercised): #; genotype times 
training interaction: x were assessed by ANOVA. Comparison between two individual 
groups: effects of training (sedentary versus exercised)(*) and genotype (wild-type versus 
MPGC-1α TG mice)(§) were assessed by t-test. Single symbol: p<0.05; double symbols: 
p<0.01; triple symbols: p<0.001. 
 
 
Fig. 6 Metabolic regulation of glucose uptake in skeletal muscle  
(A) Effect of the FAS inhibitor cerulenin on glucose uptake in the absence (white bars) or 
presence (black bars) of insulin. 
(B) Effect of the sphingosine on glucose uptake in the absence (white bars) or presence (black 
bars) of insulin. 
All values are expressed as means ±SE (n =6 per group); Overall effect of PGC-1α: @; Effect 
of drug: #; PGC-1α times drug interaction: x were assessed by ANOVA. Comparison between 
two individual groups: effects of training (sedentary versus exercised)(*) and genotype (wild-
type versus MPGC-1α TG mice)(§) were assessed by t-test. Single symbol: p<0.05; double 
symbols: p<0.01; triple symbols: p<0.001.  
 
 
Fig. 7 Integrative theoretical model  
Schematic theoretical interpretation of the findings on metabolic profiles predominating in 
response to training and PGC-1α levels.  
Sedentary state: At elevated levels of PGC-1α the increase in β-oxidation relatively exceeds 
the increase in citrate synthase activity. Consequently, acetylcarnitine accumulates and 
impairs insulin sensitivity. Citrate, produced by citrate synthase, is fuelled into OXPHOS to 
generate ATP. In the absence of physical activity, the low ATP turnover ultimately limits 
OXPHOS activity and directs metabolic fluxes away from catabolism. The elevated citrate 
synthase activity, without an elevated need to produce ATP for muscle contraction, overloads 
the Krebs cycle. Citrate is consequently exported into the cytoplasm and promotes de-novo 
lipogenesis through FAS. De-novo synthesized fatty acids are subsequently fuelled back into 
lipid oxidation or incorporated into higher lipid species. They then exert distinct effects on 
glucose homeostasis. DAG, PC and PE are used to expand mitochondrial mass, without 
impact on glucose homeostasis, while sphingosine inhibits glucose uptake. 
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Exercised state: At elevated levels of PGC-1α citrate synthase activity further increases and 
the levels of acetylcarnitine diminish. Citrate is shunted towards catabolic and anabolic 
pathways. 
Acutely, the high turn-over of ATP during muscle contraction drives further flux of lipids into 
the catabolic system. Chronically, endurance training further promotes lipid synthesis and 
storage as triglycerides. The combination of exercise and elevated muscle PGC-1α 
consequently results in an elevated activity of lipid synthesis and a concomitant increase in 
TG, DAG, PC and PE. Lipid fluxes are thus diverted away from sphingosine towards 
triglyceride biosynthesis. Moreover, the elevated levels of TG inhibit the action of 
sphingosine and relieve any inhibitory effect. The high FAS activity will drive glucose uptake 
into skeletal muscle and thus removal of glucose from the circulation. 
Arrows/lines: dashed, basal conditions; straight, altered at elevated PGC-1α levels or exercise; 
light, chronic elevation; dark, additional elevation during acute exercise. 
Boxes/lines: red, insulin-desensitizing metabolites; blue, neutral metabolites in respect to 
insulin sensitivity. 
 







